首页> 外文OA文献 >Assessment of Airway Bronchodilation by Spirometry Compared to Airway Obstruction in Young Children with Asthma
【2h】

Assessment of Airway Bronchodilation by Spirometry Compared to Airway Obstruction in Young Children with Asthma

机译:与血管梗阻的血管梗阻评估气道支气管的评估与哮喘的幼儿

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A reversibility test by an increase of greater than 12% in FEV1 can support a diagnosis of asthma and alter a patient’s treatment plan but may not be applicable to the young ages. We retrospectively gathered spirometric data from 85/271 asthmatic children having mild obstruction (FEV1 > 80% predicted), age 2.6–6.9 years. Spirometry was performed before and 20 min after inhalation of 200 mcg Albuterol. We defined a deviation below −1.64 z scores from control as obstruction and an increased above 1.64 scores from control as a positive response to bronchodilators. Sensitivity of the index was considered significant if it captured >68% of the participants. The sensitivity of detecting airway obstruction in these children by FEV1 was 15.3% and 62.4% by FEF25–75. A positive response to Albuterol was an increase of 9.2% for FEV1 (12% for adults) and 18.5% for FEF25–75. The sensitivity for detecting a response to Albuterol in mild asthma was 64.7% by FEV1 and 91.8% by FEF25–75. Young children having normal spirometry can demonstrate airway reversibility. The response of spirometry parameters to bronchodilators may be more sensitive than obstruction detection and may help to support the diagnosis of asthma and adjust treatment plan.
机译:在FEV1中,可逆性测试在FEV1中增加大于12%,可以支持哮喘的诊断,并改变患者的治疗计划,但可能不适用于年轻年龄。我们回顾性地收集了85/271哮喘儿童的肺活动力数据(FEV1> 80%预测),年龄为2.6-6.9岁。在吸入200mcg苯甲甾醇之前,在吸入后进行肺活量测定法。我们定义了低于-1.64 z的偏差,从控制中的梗阻从控制增加,从控制中增加1.64分作为对支气管扩张剂的阳性反应。如果它捕获> 68%的参与者,指数的敏感性被认为是重要的。通过FEV1检测这些儿童气道阻塞的敏感性为FeF25-75的15.3%和62.4%。对白甲醇的阳性反应为FEV1(成人12%)的9.2%,FEF25-75的18.5%。通过FeF1和91.8%的FeF1和91.8%检测对轻度哮喘的反应的响应的灵敏度为64.7%。患有正常肺活量测定的幼儿可以展示气道可逆性。肺炎参数对支气管扩张剂的响应可能比阻塞检测更敏感,并且可以有助于支持哮喘的诊断和调整治疗计划。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号